Complex Regional Pain Syndrome Medicine

STAT+: Flagship’s latest startup launches with bold claim: the discovery of thousands of new human proteins

This post originally appeared on StatNews.

A Cambridge, Mass., biotech company claims to have made a discovery that could rewrite biology textbooks. ProFound Therapeutics said Thursday that it had identified tens of thousands of previously unknown proteins in the human body, many of which may be involved in cancer, immunity, and metabolism.

After two years of working in stealth, ProFound has emerged with $75 million from Flagship Pioneering, the Cambridge investment firm that builds and funds its own biotech companies and is best known for its creation of the mRNA vaccine developer Moderna. ProFound will use the money to catalogue and study the new proteins, begin building a pipeline of drugs based on their findings, and potentially quadruple in size from about 25 to 100 employees by this time next year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

This post originally appeared on StatNews.